Pacira BioSciences, Inc. (PCRX)

NASDAQ: PCRX · Real-Time Price · USD

26.11

+0.12 (0.44%)

At close: Aug 27, 2025, 4:00 PM

26.13

+0.02 (0.10%)

After-hours: Aug 27, 2025, 4:20 PM EDT

Pacira BioSciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	705.85	700.97	674.98	666.82	541.53	429.65	Upgrade
Revenue Growth (YoY)	2.25%	3.85%	1.22%	23.14%	26.04%	2.05%	Upgrade
Cost of Revenue	236.42	252.01	260.93	284.09	195.8	176.75	Upgrade
Gross Profit	469.43	448.96	414.05	382.73	345.73	252.9	Upgrade
Selling, General & Admin	329.3	294.1	269.44	254.52	199.35	193.52	Upgrade
Other Operating Expenses	-	-	-	-	42.91	-	Upgrade
Operating Expenses	400.99	351.39	326.73	311.8	255.81	201.38	Upgrade
Operating Income	68.44	97.57	87.32	70.93	89.92	51.52	Upgrade
Interest Expense	-18.64	-16.57	-20.31	-39.98	-31.75	-25.67	Upgrade
Interest & Investment Income	22.94	19.69	11.44	4.54	0.9	4.63	Upgrade
Other Non Operating Income (Expenses)	-6.51	-0.37	-0.19	-1.29	-0.07	1.23	Upgrade
EBT Excluding Unusual Items	66.23	100.32	78.28	34.21	59	31.71	Upgrade
Merger & Restructuring Charges	-5.56	-9.99	-3.07	-11.25	-	0.04	Upgrade
Impairment of Goodwill	-163.24	-163.24	-	-	-	-	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	-10	-2.6	1.62	Upgrade
Asset Writedown	-	-	-	-26.13	-	-	Upgrade
Legal Settlements	-7	-	-	-	-	-	Upgrade
Other Unusual Items	3.03	9.81	-13.5	26.48	-	-13.28	Upgrade
Pretax Income	-106.55	-63.11	61.7	13.3	56.4	20.09	Upgrade
Income Tax Expense	20.91	36.45	19.75	-2.61	14.42	-125.43	Upgrade
Net Income	-127.46	-99.56	41.96	15.91	41.98	145.52	Upgrade
Net Income to Common	-127.46	-99.56	41.96	15.91	41.98	145.52	Upgrade
Net Income Growth	-	-	163.72%	-62.10%	-71.15%	-	Upgrade
Shares Outstanding (Basic)	46	46	46	46	44	43	Upgrade
Shares Outstanding (Diluted)	46	46	52	47	46	44	Upgrade
Shares Change (YoY)	-15.61%	-11.03%	11.69%	1.99%	4.46%	5.22%	Upgrade
EPS (Basic)	-2.77	-2.15	0.91	0.35	0.95	3.41	Upgrade
EPS (Diluted)	-2.81	-2.15	0.89	0.34	0.92	3.33	Upgrade
EPS Growth	-	-	160.68%	-63.04%	-72.37%	-	Upgrade
Free Cash Flow	117.07	178.75	139.49	115.2	79.85	39.23	Upgrade
Free Cash Flow Per Share	2.54	3.87	2.68	2.48	1.75	0.90	Upgrade
Gross Margin	66.51%	64.05%	61.34%	57.40%	63.84%	58.86%	Upgrade
Operating Margin	9.70%	13.92%	12.94%	10.64%	16.61%	11.99%	Upgrade
Profit Margin	-18.06%	-14.20%	6.22%	2.39%	7.75%	33.87%	Upgrade
Free Cash Flow Margin	16.59%	25.50%	20.67%	17.28%	14.74%	9.13%	Upgrade
EBITDA	158.43	176.36	162.9	151.93	118.47	71.42	Upgrade
EBITDA Margin	22.45%	25.16%	24.13%	22.78%	21.88%	16.62%	Upgrade
D&A For EBITDA	89.99	78.79	75.57	81	28.55	19.91	Upgrade
EBIT	68.44	97.57	87.32	70.93	89.92	51.52	Upgrade
EBIT Margin	9.70%	13.92%	12.94%	10.64%	16.61%	11.99%	Upgrade
Effective Tax Rate	-	-	32.00%	-	25.57%	-	Upgrade
Revenue as Reported	705.85	700.97	674.98	666.82	541.53	429.65	Upgrade

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q